Arteriosclerosis is the broad term for any hardening or stiffening of the arteries, regardless of cause. Atherosclerosis is one specific type of arteriosclerosis, caused by fatty plaque building up inside artery walls. All atherosclerosis is arteriosclerosis, but not all arteriosclerosis is atherosclerosis. The two terms are often used interchangeably, but they describe different levels of the same problem.
Arteriosclerosis Is the Umbrella Term
Arteriosclerosis simply means your arteries have become thicker, stiffer, or less flexible than they should be. It doesn’t specify why. Age, high blood pressure, diabetes, and chronic inflammation can all cause arteries to lose their elasticity over time. Think of it as a category, not a single disease.
Under that umbrella, there are three main subtypes:
- Atherosclerosis: fatty plaque accumulates in the inner lining of large and medium-sized arteries. This is by far the most common form.
- Arteriolosclerosis: thickening of tiny arterioles, the smallest arterial vessels, usually driven by high blood pressure.
- Mönckeberg medial sclerosis: calcium deposits form in the middle muscular layer of artery walls, a pattern distinct from plaque buildup.
How Atherosclerosis Develops
Atherosclerosis targets the innermost layer of the artery wall, called the intima. It begins when that layer gets irritated or damaged, often by high cholesterol, high blood pressure, or smoking. In response, smooth muscle cells in the artery wall start to multiply and produce extra structural material, thickening the intima in patches rather than uniformly.
Fats, particularly LDL cholesterol, seep into these thickened patches and pool in the deeper layers. Immune cells, especially a type called macrophages, move in to clean up the fat but end up dying in the process, creating a soft, unstable core of dead cells and lipids. This is the beginning of a full plaque, known as a fibroatheroma. The body tries to stabilize it by forming a fibrous cap of smooth muscle cells over the top.
The real danger comes when that cap thins. A thin-cap plaque is infiltrated with inflammatory cells that weaken its structure. If the cap ruptures, the contents of the plaque are exposed to blood, triggering a clot that can block the artery entirely or break loose and travel elsewhere. This is the mechanism behind most heart attacks and many strokes.
How the Other Types Differ
Arteriolosclerosis affects vessels far smaller than those involved in atherosclerosis. These tiny arterioles regulate blood flow to organs like the kidneys and brain. When they thicken, usually from years of high blood pressure, blood flow to those organs gradually drops. This form of arteriosclerosis is a major contributor to kidney damage and a type of cognitive decline called vascular dementia.
Mönckeberg medial sclerosis takes a completely different path. Instead of plaque forming in the inner lining, calcium crystals (hydroxyapatite) deposit in the middle, muscular layer of the artery. Over time, this calcification can become ring-shaped, sometimes even forming actual bone tissue within the artery wall. On an X-ray, it shows up as smooth, parallel lines, sometimes described as a “railroad track” pattern, which looks very different from the chunky, irregular calcification of atherosclerosis. Mönckeberg sclerosis often produces no symptoms for years and may never be diagnosed. It doesn’t narrow the artery the way plaque does, so patients typically don’t experience the classic cramping pain of blocked leg arteries. In some cases, though, it can eventually impair blood flow enough to cause tissue damage, particularly in older adults.
Different Arteries, Different Consequences
Because atherosclerosis targets large and medium arteries, its complications depend on which arteries are involved. Plaque in the coronary arteries leads to heart attacks. In the carotid arteries supplying the brain, it causes strokes or mini-strokes (sometimes first detected as a whooshing sound a doctor hears through a stethoscope). In the renal arteries, it restricts blood flow to the kidneys. In the legs, it causes peripheral artery disease, with pain during walking that eases with rest.
Arteriolosclerosis, by contrast, does its damage silently in much smaller vessels. It’s closely linked to chronic kidney disease and small-vessel disease in the brain. Mönckeberg sclerosis tends to affect arteries in the limbs and can complicate blood pressure readings by making arteries so stiff that a cuff gives falsely high numbers.
Different Causes and Risk Factors
Atherosclerosis is fundamentally an inflammatory disease. Its biggest drivers are high LDL cholesterol, smoking, high blood pressure, diabetes, and metabolic syndrome. Inflammatory conditions like rheumatoid arthritis and psoriasis also raise the risk. These factors damage the artery lining and set off the chain of fat accumulation, immune response, and plaque growth described above.
The non-atherosclerotic forms of arteriosclerosis have overlapping but distinct triggers. Arteriolosclerosis is most strongly tied to sustained high blood pressure and diabetes. Mönckeberg sclerosis is linked to aging, kidney disease, and disorders of calcium metabolism. It can occur alongside atherosclerosis, but the two processes happen in different layers of the artery wall and progress independently.
Treatment Targets Differ Too
Because the underlying mechanisms are different, treatment priorities shift depending on which type of arteriosclerosis you’re dealing with. Atherosclerosis management centers on lowering LDL cholesterol and reducing plaque inflammation. Cholesterol-lowering medications can slow plaque growth and, in some cases, stabilize vulnerable plaques so they’re less likely to rupture. Blood pressure control, blood sugar management, quitting smoking, and regular exercise are all core parts of the approach.
For general arterial stiffness, the emphasis shifts toward blood pressure control and strategies that target the structural changes in artery walls. Lowering blood pressure remains the single most effective way to reduce stiffness. Exercise training has also shown consistent benefits for improving arterial flexibility, likely by influencing how artery walls remodel over time. Some blood pressure medications appear to have stiffness-reducing effects beyond simply lowering pressure, though the blood pressure reduction itself does most of the work.
Mönckeberg sclerosis has no established treatment that reverses the calcification. Management focuses on monitoring blood flow, controlling any underlying conditions like kidney disease, and watching for signs that perfusion to the limbs is dropping.
Why the Distinction Matters
In everyday conversation, “hardening of the arteries” and “clogged arteries” get treated as the same thing. Clinically, they’re not. An artery can be stiff without being clogged, and a clogged artery isn’t always particularly stiff. Knowing which process is at work changes what doctors look for, what tests they order, and what treatments they recommend. If you’ve been told you have arterial stiffness, that’s a broader finding about how flexible your blood vessels are. If you’ve been told you have atherosclerosis, that’s a specific diagnosis involving plaque, and it carries a specific set of risks, particularly the possibility of a plaque rupturing and causing an acute event like a heart attack or stroke.